-
Phase II of ALS stem cell trial underway at Emory and University of Michigan
Emory’s NSI-566/ALS Site Principal Investigator, Jonathan D. Glass, MD, and Co-Investigator and Neurosurgeon Nicholas M. Boulis, MD, who designed Neuralstem’s proprietary, patented spinal platform and floating cannula specifically for the world’s first delivery of cells directly into the gray matter of the spinal cord, are interviewed about the Phase II trial now underway.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.